Deep Learning to Distinguish Benign from Malignant Renal Lesions Based on Routine MR Imaging

Abstract

Deep learning can noninvasively distinguish benign renal tumors from RCC using conventional MR imaging in a multi-institutional dataset with good accuracy, sensitivity, and specificity comparable with experts and radiomics.